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Toll-like receptor 2 (TLR2) signaling has been shown to contribute to resistance to Listeria monocytogenes infec-
tion, as TLR2-deficient mice have a heightened susceptibility to infection with this organism. Because CD14may
associate with TLR2, we investigated the role of CD14 in Listeria responses. In both CD14-deficient and TLR2-
deficientmacrophages, nuclear factorB translocation; CD40 andCD86; and the production of interleukin (IL)–
12, IL-6, tumor necrosis factor, and nitric oxide are reduced. The absence of CD14 augmented susceptibility to
Listeria infection, reduced survival, anddiminishedbacterial clearance, as observed inTLR2-deficientmice.Com-
paredwith C57BL/6 controlmice, CD14-deficientmice were observed to have a greater number of hepaticmicro-
abscesses containing abundant neutrophils, these abscesses were larger in size, and there was reduced inducible
nitric oxide synthase expression. Further, mice that are both CD14 deficient and TLR2 deficient display suscepti-
bility to infection that is comparable to that ofmice deficient in eitherCD14orTLR2 alone. Therefore, the present
data demonstrate the role of CD14 and TLR2 in the recognition and control of Listeria infection and host
resistance.
Toll-like receptors (TLRs) recognize a wide range of mi-
crobial pathogens, and their products modulate the in-
nate immune response that may lead to inflammation
and altered host defense [1–3]. We previously reported
that TLR2 signaling can be shown to contribute to resis-
tance to Listeria monocytogenes infection because TLR2-
deficient mice have a higher susceptibility to infection
with this organism [4]. The involvement of the TLR sig-
naling pathwaywas further confirmed by the heightened
susceptibility of myeloid differentiation primary re-
sponse gene (88) (MyD88)–deficient mice [5, 6]. Hav-
ing tested several other TLRs, such as TLR3, TLR4, and
TLR9, by using gene-deficient mice, we concluded that
they play no role in Listeria-induced immune activation
(unpublished data), which emphasizes the role of TLR2
in the immune response to Listeria. Because TLR2 may
associate with other membrane receptors for pathogen
recognition, we asked whether CD14 might contribute
to the TLR2-mediated response to Listeria.
Together with TLR4 and MD2, CD14 is critical for
the recognition of lipopolysaccharide (LPS) and/or
endotoxin from gram-negative bacteria by different
host cells that initiate cell activation and the release
of proinflammatory cytokines [7, 8]. CD14 is not
an obligatory coreceptor of TLR4. Indeed, in LPS-
induced, TLR4-mediated acute lung injury, CD14
is required in response to low doses of LPS but is less
critical at higher doses of LPS [9]. CD14 may par-
ticipate in MyD88-independent, Toll/interleukin-1
receptor (TIR) domain-containing adaptor inducing
interferon-–mediated and/or TIR domain-containing
adaptor inducing interferon-–related adaptor mole-
cule–mediated signalling of rough LPS or lipid A [10].
CD14 is also involved in corecognition by TLR2 of var-
ious TLR ligands, such as peptidoglycan from Staphylo-
coccus aureus and Streptococcus pneumonia [11] and hu-
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man cytomegalovirus [12], and secreted microbial products
from group B Streptococcus [13]; lipoteichoic acid–induced cell
activation also depends on CD14 [14]. By using neutralizing an-
tibodies to CD14 in TLR2-transfected CHO cells, the induction
of tumor necrosis factor (TNF) production by killed L. monocy-
togenes was shown to depend, in part, on CD14 associated with
TLR2 [15]. Typically, this is the case for the synthetic bacterial
lipopeptide Pam3CSK4, signaling through heterodimers of
TLR2 and TLR1, whereas diacylated Pam2CSK4, MALP2 or zy-
mosan that signal throughTLR2 and/or TLR6 require CD14 [10,
16]. CD14 may, however, participate to a lesser extent in signal-
lingmediated by the TLR2-TLR6 complex than in signallingme-
diated by TLR4, because the TLR2-TLR6 complex was also
shown to associate with CD36 [17]. Recently, activation of TLR3
has been shown to be enhanced by CD14, and an association of
TLR3 and CD14 with the activating ligand has been demon-
strated [18]. However, several TLR ligands recognize and acti-
vate cells independently of CD14.
In this study, we investigated whether CD14 participates in
the host response to Listeria infection. There are a number of
reasons to think that this is the case. First, CD14-deficient mac-
rophages have a reduced proinflammatory response and re-
duced nitric oxide (NO) production. Second, CD14-deficient
mice display diminished resistance to intravenous Listeria infec-
tion, similar to TLR2-deficient mice, and mice that are both
TLR2 deficient and CD14 deficient are nomore susceptible than
mice deficient in either gene alone. Finally a role for TLR4 is
excluded in this response. Therefore, the data suggest that CD14
is acting together with TLR2 to mount an efficient innate im-
mune response to Listeria.
METHODS
Mice and infection. Mice 8–12 weeks old that were CD14
deficient (obtained from M.W Freeman [19]), TLR4 deficient
[20], TLR2 deficient [21], TLR2 deficient and CD14 deficient
(obtained from R. Landmann), or MyD88 deficient [22] and
C57BL/6 control mice were used in this study. All mice were
backcrossed for 10 generations onto the C57BL/6 background
and bred under specific pathogen-free conditions at the Trans-
genose Institute (Centre National de la Recherche Scientifique).
The animal experiments complied with the French govern-
ment’s ethical and animal experiment regulations. L. monocyto-
genes (L028 strain; Pasteur Institute) was cultured in LPS-free
trypticase soy broth (soybean casein digest medium; Biovalley)
and was aliquoted and stored in 30% glycerol at 80°C until
use [4].
CD14-deficient mice, TLR2-deficient might, TLR4-deficient
mice, CD14-deficient and TLR2-deficient mice, MyD88-
deficient mice, and C57BL/6 control mice were injected in the
caudal vein with 3  104 colony-forming units (cfu) permouse.
On days 2 and 3, livers and spleens were harvested. The organs
were homogenized by use of a disposable homogenization sys-
tem (Dispomix; Medictools AG), and the number of viable bac-
teria (colony-forming units) in the homogenates was deter-
mined by plating serial dilutions on trypticase soy broth agar
plates (Biovalley) incubated at 37°C for 24 h as described else-
where [4].
Primary macrophage culture. Murine bone marrow cells
were isolated from femurs and differentiated into macrophages
after culturing 106 cells/mL for 7 days in Dulbecco’s modified
Eagle medium (DMEM) (Sigma) supplemented with 20% horse
serum and 30% L929 cell-conditioned medium (as a source of
macrophage colony-stimulating factor) [23]. Three days after
washing and reculturing in fresh medium, the cell prepara-
tion contained a homogenous population of macrophages
(97% CD11b cells). Bone marrow–derived macrophages
(BMDMs)were plated in 96-wellmicrotiter culture plates (at 105
cells/well) by using serum-free DMEM (free of sCD14 and
lipopolysaccharide-binding protein) with 100 U of interferon
(IFN)  and stimulated with LPS (LPS of Escherichia coli, sero-
type O111:B4 [Sigma], at 100 ng/mL), and L. monocytogenes (at
MOI 1:2, e.g., 2  106 cfu/mL). The viability of the macro-
phages as tested by trypan blue exclusion was not affected. After
6 h and 18 h of stimulation, the supernatants were harvested for
cytokine determination.
Cytokine and nitric oxide (NO) determination. TNF, in-
terleukin (IL)–12p40, or IL-6 were quantified in cell-free super-
natants from cell culture by use of commercial ELISA with a
detection limit of 5 pg/mL (Duoset; R&D Systems). Nitrite
(NO2; derived fromNO breakdown) concentrations in super-
natants from macrophages were determined by use of Griess
reagent (1% sulphanilamide in 2.5%phosphoric acid, 0.1%n-1-
napthylethylenediamide dichloric in 2.5%phosphoric acid [24].
After 30 min incubation at room temperature under agitation,
the absorbance at 540 nm was measured. NO2 was quantified
using sodium nitrite (NaNO2) as a standard.
Microscopic evaluation of liver tissue. Livers were fixed in
10% buffered formalin (Shandon). Tissues were dehydrated in
ethanol and embedded in paraffin. Sections (3m)were cut and
stained with haematoxylin and eosin for evaluation of patho-
logic changes. The number of microabscesses was quantified by
counting in 20 microscopic fields at 100 magnification. The
diameter of microabscesses was evaluated at 400 magnifica-
tion by using an ocular grid, and 50 microabscesses were mea-
sured by 2 independent observers [4].
NO synthase type 2 (NOS2) expression in paraffin-embedded
sections of liver tissue. Paraffin-blocked tissue slides were rehy-
drated through xylene, 100% ethanol, 96% ethanol, and 70% etha-
nol to water. To unmask epitopes, sections were placed in citrate
buffer, heated for 10min in amicrowaveoven, andfixed for 10min
in acetone. Endogenous peroxidase activity was blocked by 1%
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H2O2 inmethanol for 30min, and endogenous biotin was blocked.
Slides were incubated for 2 h at room temperature with the rabbit
anti–mouse inducible nitric oxide synthase (NOS2) primary anti-
body (1:1000 dilution; supplied by J. Pfeilschifter), followed by in-
cubation with biotinylated goat anti–rabbit antibody and revealed
by use of the ABC Vector Kit for 30 min. Slides were washed and
incubated for 10min in fresh diaminobenzidine substrate. Sections
were incubated for 2 min in 1% CuSO4, counterstained with
haematoxylin, dehydrated through 70% ethanol, 96% ethanol,
100% ethanol to xylene and mounted in Eukitt (O.Kindler) for
semiquantitative analysis by light microscopy.
Flow cytometry analysis of macrophages and cells obtained
from liver tissue. After stimulation, macrophages were har-
vested, washed once in PBS that contained 0.5% bovine serum
albumin (BSA), and incubated on ice at 105 cells/50 L with
primary antibodies (anti–CD40-PE [clone 3/23], anti–CD86–
fluorescein isothiocyanate [FITC] [clone GL1], and anti–
CD11b-PerCP Cy5.5 [clone M1/70]) for 20 min in the dark. All
Figure 1. CD14-dependent production of proinflammatory cytokines in Listeria monocytogenes (LM)–infected bone marrow–derived macrophages (BMDMs).
BMDMs from C57BL/6 control mice(black bars) and CD14-deficient (/) mice (white bars) were unstimulated (medium) or stimulated for 18 h with live L.
monocytogenes (MOI, 1:2 [as described in the Methods section]) or lipopolysaccharide (LPS) (100 ng/mL). The concentrations of interleukin (IL)–12p40 (A), IL6
(B), tumor necrosis factor (TNF) (C) and nitric oxide (NO) (D) in the supernatant were determined by ELISA (for IL-12p40, IL-6, and TNF) and by the Griess method
(for NO). Graphs show results of 1 experiment representative of 2 independent experiments, expressed as mean  SD (*P  .05, ***P  .001). E,
Bacteriocidal activity of macrophages from CD14/ mice and C57BL/6 control mice assessed in vitro, as described in the Methods section. Graph
shows results of 1 experiment representative of 2 independent experiments; number of viable bacilli are expressed as mean  SD (n  4). /,
deficient; ND, not detectable.
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antibodies were obtained from BD Pharmingen. After washing
with PBS that contained 0.5% BSA, cells were analyzed on a
Becton Dickinson LSR analyzer.
For the flow cytometric analysis of inflammatory cells in the
liver, mice were euthanized and the organs perfused with saline.
Spleens and livers were minced with scissors, pressed through a
nylon filter, resuspended in Percoll 33% gradient, and centri-
fuged at 1000 g for 20 min. Erythrocytes in the pellet were lysed
with 155mmol/LNH4Cl, 10mmol/LNaHCO3, and 0.1mmol/L
EDTA for 5 min on ice. Finally, the cells were resuspended in
PBS that contained 0.5% BSA for fluorescence-activated cell
sorter analysis using the protocol and antibodies described
above.
Nuclear translocation of nuclear factor B (NF-B) in
macrophages. BMDMswere grown onmicroscopic slides in the
presence of 10U IFNovernight and then incubatedwithL.mono-
cytogenes (MOI, 1:2) for 1h ,washedwithPBS, and thenfixed in 4%
paraformaldehyde and permeabilized with 0.5% Triton X-100.
Macrophages were incubated with goat anti–murine NF-Bp65
mAb for 1 h at room temperature, washed and incubated with
swine anti–goat IgG FITC (Sigma). The nuclear translocation of
NF-B was assessed by fluorescence microscopy and 200 cells per
groupwere counted. The nuclear translocation was confirmed and
documented by confocal microscopy (Leica SP2).
Macrophage killing assay. The bactericidal activity of mac-
rophages was determined as described elsewhere [25]. In brief,
cells were plated in 24-well tissue culture plates (106 cells/well) in
the presence of 100 U IFN overnight and then exposed to L.
monocytogenes (MOI, 1:2 [e.g., 106 cells/mL per 2  106 cfu/
mL]). After 30 min incubation at 37°C, gentamycin (10g/mL)
was added, and the cells were harvested immediately or after
incubation periods of 1.5 h, 3 h, and 5 h and washed 3 times
(each wash was with 1 mL of DMEM that contained 10% fetal
calf serum). The supernatant was plated at 10-fold dilutions on
trypticase soy broth (Biovalley), as described above. The plates
were incubated at 37°C, and the number of colony-forming
units was enumerated after 24 h.
Statistical analysis. The statistical evaluation of differences
between the experimental groups was performed by the use of
the log rank test for survival studies and the Student’s t test.
Figure 2. Reduced resistance of CD14-deficient (/) mice infected with Listeria monocytogenes. We injected 3  104 colony-forming units of
Listeria intravenously into CD14/ mice (A), TLR2/ mice (B), TLR4/ mice (C), CD14/ and TLR2/ mice (D), and MyD88/ mice (E).
Survival rates were compared to that of C57BL/6-infected control mice during a 10-day period (for 6 mice per group). Graphs show results from 1
experiment representative of 2 independent experiments (*P  .05, **P  .01, determined by log rank test).
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RESULTS
Reduced production of IL-12p40, IL-6, TNF, and NO in
CD14–deficient macrophages stimulated by Listeria. To
characterize the role of CD14 for proinflammatory cytokine
production in response to L. monocytogenes, primary bone mar-
row–derived macrophages from CD14-deficient mice and
C57BL/6 control mice were stimulated with L. monocytogenes.
The production of IL-12p40, IL-6, and, to a lesser extent, TNF
was significantly reduced after L. monocytogenes activation of
CD14-deficient macrophages at 6 h (not shown) and 18 h (fig-
ures 1A–1C), compared with cells from control mice, without
affecting the cells’ viability. As expected, the cytokine responses
to low doses of LPS were abrogated in CD14-deficient macro-
phages (figure 1), as was also seen in TLR4-deficient macro-
phages (not shown). A similar reduction in cytokine production
in response to L. monocytogenes infection is seen in TLR2-
deficient and MyD88-deficient macrophages, as reported else-
where [4].To explore the potential mechanisms of a bactericidal
effect, we measured NO production. Macrophages from CD14-
deficientmice produced less NO in response to L.monocytogenes
infection, compared with macrophages from control mice (fig-
ure 1D) (P  .05). Despite diminished NO production, there
was no significant reduction of bacterial killing by macrophages
from CD14-deficient mice (figure 1E) (P  .05).
Therefore, the data suggest that CD14 is involved in L. mono-
cytogenes–induced macrophage activation. In view of the re-
duced proinflammatory cytokine and NO production, we hy-
pothesized that host resistance to infectionwith this intracellular
pathogen may be diminished in CD14-deficient mice.
Reduced resistance and bacterial clearance in Listeria-
infected, CD14-deficient mice. Because L. monocytogenes
activates macrophages in a CD14-dependent and TLR2-
dependent manner, we asked whether the CD14 engagement
contributes to TLR2-dependent resistance to an in vivo L.mono-
cytogenes infection. We compared the resistance of C57BL/6
control mice and CD14-deficient mice to a systemic injection of
L. monocytogenes. Intravenous infection with 3  104 cfu per
mouse caused death in 60% of CD14-deficient mice within 5
days, whereas all control mice survived (figure 2A). TLR2-
deficient mice display a similar susceptibility to infection,
whereas TLR4-deficient mice are resistant (figures 2B and 2C).
To test whether therewas an additive effect when bothCD14 and
TLR2 genes were inactivated, we usedmice that were both CD14
deficient and TLR2 deficient; their susceptibility to L. monocy-
togenes infectionwas comparable to that of single gene–deficient
mice (figure 2D). In contrast, we confirm that MyD88-deficient
mice are highly sensitive to L. monocytogenes infection (figure
2E), as we reported before [6]. Therefore, these data clearly show
that CD14-deficient mice have heightened susceptibility to L.
monocytogenes infection.
In view of their increased sensitivity to infection with this or-
ganism, we asked whether the rate of bacterial clearance might
be reduced in CD14-deficient mice. The bacterial load in spleen
and liver tissue from control and CD14-deficient mice that had
been infected with 3  104 cfu of L. monocytogenes per mouse
was analyzed. Three days after infection, CD14-deficient mice
displayed 2 log higher levels of colony-forming units in the
liver and 1 log higher levels in the spleen, compared with wild-
type control mice, and MyD88-deficient mice had significantly
higher levels than control mice (figures 3A and 3B). TLR2-
deficient mice and mice deficient in both CD14 and TLR2 dis-
played an increase in the number of viable bacteria in the liver
and spleen that was comparable to that seen in mice that lacked
CD14 expression alone, without evidence of an additive effect
(figure 3). Therefore, reduced host resistance in the absence of
CD14 and/or TLR2 is associated with a significant increase of
bacilli in the liver. As consequence of the higher bacterial load,
augmented inflammation with an increased number of hepatic
microabscesses was expected.
Augmented hepatic inflammatory response in Listeria-
infected, CD14-deficient mice. Microscopic examination of
liver tissue at low magnification revealed distinct differences in
Figure 3. Reduced rate of bacterial clearance from the liver and
spleen of CD14-deficient mice infected with Listeria monocytogenes.
Bacterial load in the liver (A) and spleen (B) of CD14-deficient (/)
mice, TLR2/ mice, CD14 / and TLR2/ mice, TLR4/ mice,
MyD88/ mice, and C57BL/6 control mice 3 days after infection with
3  104 colony-forming units of L. monocytogenes (4 per group). Each
symbol indicates the liver or spleen of 1 mouse. Results are from 1
experiment representative for 2 independent experiments and are ex-
pressed as mean  SD (*P  .05, **P  .01. NS, not significant.
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the hepatic microabscesses observed in CD14-deficient mice,
compared with those observed in C57BL/6 control mice (figure
4A) 3 days after infection. The hepatic microabscesses in CD14-
deficient mice were generally larger, less confined, and partially
confluent. The number of abscesses was significantly increased
in CD14-deficient mice (figure 4B). Moreover, the microab-
scesses in these mice had less-defined boundaries, contained
more abundant neutrophils and necrotic tissue (figure 4C), and
were larger (figure 4D), comparedwith the abscesses observed in
control mice. Further, as an indicator of reduced phagocyte ac-
tivation and bactericidal activity in vivo, NOS2 expression in
infected liver tissue was clearly reduced in CD14-deficient mice,
compared with control mice (figure 4E). Therefore, the absence
of CD14 is associated with reduced NOS2 expression, enhanced
neutrophil recruitment, and formation of large microabscesses
in the liver.
Flow cytometric analysis of the inflammatory cells in the liver
at 2 days after infection, when the bacterial loads are comparable
between the experimental groups (data not shown), revealed de-
creased expression of CD40 by CD11b cells from CD14-
deficient mice, compared with cells fromC57BL/6 control mice,
which suggested reduced activation of monocytes and/or mac-
rophages in the liver (figure 5). In contrast, the number of Gr1
neutrophils is slightly increased at the same time point (not
shown), as shown by microscopic examination of the tissue sec-
tions.
CD14- and TLR2-dependent activation of NF-B and co-
stimulatory molecules. To further dissect potential crosstalk
between the TLR2 and CD14 receptor pathways, we assessed the
translocation of cytosolic NF-B into the nucleus in BMDMs at
several time points after L. monocytogenes infection. Although
uninfected macrophages from control mice did not show any
significant nuclear staining, incubation with L. monocytogenes
induced rapid nuclear translocation of NF-B in macrophages
fromC57BL/6mice, which reached amaximum at 1 h with 64%
of macrophages showing nuclear staining. In contrast, nuclear
Figure 4. More abundant and larger hepatic microabscesses observed in CD14-deficient (/) mice. C57BL/6 and CD14/ mice were infected
with 3  104 colony-forming units of Listeria monocytogenes and liver tissue was histologically examined 3 days after infection (4 mice per group).
Sections of liver tissue showing small, confined microabscesses in wild-type mice and spreading infection in CD14/ mice (A) (hematoxylin and eosin
staining, 100). Increased numbers of microabscesses in CD14/ mice, compared with C57BL/6 controls (B). Histological sections of liver tissue
showing small, confined microabscesses in wild-type mice and spreading infection in CD14/ mice (C) (hematoxylin and eosin staining, 400). D,
Mean diameter of microabscesses in millimeters. Graphs show results from 1 experiment representative of 2 independent experiments expressed as
mean  SD (*P  .05, **P  .01). E, Reduced expression of inducible nitric oxide synthase in the liver of CD14/ mice. Immunostaining was
performed at 3 days after infection in C57BL/6 control mice and CD14/ mice by immunohistochemical analysis (100 and 400) (n  4).
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translocation was absent in macrophages from CD14-
deficient or TLR2-deficient mice after L. monocytogenes infec-
tion (figure 6A). Therefore, L. monocytogenes induced NF-B
activation through CD14 and TLR2 with similar kinetics and
magnitude. Further, reduced NF-B activation was found
to be associated with diminished upregulation of CD40 and
CD86 expression in macrophages from CD14-deficient mice
and TLR2-deficient mice infected with L. monocytogenes,
compared with macrophages from control mice (figure 6B).
Therefore, both NF-B and costimulatory molecule expres-
sion are reduced to a similar extent in macrophages from
CD14-deficient mice or TLR2-deficient mice. The data
suggest that CD14 and TLR2 sense molecular patterns
expressed by L. monocytogenes in concert. Reduced macro-
phage activation, cytokine production, and NO production
may explain reduced in vivo host responses with dimin-
ished rates of bacterial clearance and enhanced inflamma-
tion observed in CD14-deficient mice and TLR2-deficient
mice.
DISCUSSION
The present data demonstrate for the first time, to our knowl-
edge, that CD14-deficient mice have an increased sensitivity to
L. monocytogenes infection with reduced survival rates due to
impaired activation and killing of phagocytes that results in re-
duced rates of bacterial clearance and augmented inflammatory
pathology. In fact, in macrophages stimulated by L. monocyto-
genes, the production of IL-12p40, IL-6, NO, and, to a lesser
extent, TNF that depends in part on TLR2 signaling, but not on
TLR4 signaling, is reduced. These results are in agreement with
those of Flo et al., who demonstrated that CD14 neutralization
reduced TNF production in TLR2-transfected CHO cells acti-
vated by heat killed L. monocytogenes [15]. In the present study,
we show that cytokine and NO production by primary macro-
phages stimulated with live L. monocytogenes is dependent on
CD14 and TLR2 [4]. In addition, the nuclear translocation of
NF-B and expression of the costimulatorymolecules CD40 and
CD86 are diminished in the absence of either of CD14 or TLR2.
In conformity with our results, reduced cytokine production in
macrophages from TLR2-deficient mice has been shown [26]
and reduced serum levels of IFN, TNF, and IL-12 have been
reported in these mice [5]. Furthermore, we extend this obser-
vation and demonstrate a role for CD14 in in vivo Listeria infec-
tion. Reduced resistance to Listeria infection is seen in both
CD14-deficient and TLR2-deficient mice. Moreover, mice defi-
cient in CD14 or TLR2 alone and mice deficient in both CD14
and TLR2 display comparable reduction in host resistance, with
increased of bacterial load and enhanced acute hepatic inflam-
mation. The discrepancy between the susceptibility reported
previously in TLR2-deficientmice [6, 27] and our data heremay
be explained by different routes of infection (intraperitoneal
versus intravenous), the number of backcrosses of the mice, and
the strains of Listeria used.
The involvement of CD14 agrees well with our unpublished
data that suggest L. monocytogenes signals through TLR2-TLR6
complexes. Indeed, ligands of TLR2-TLR6heterodimers, such as
Pam2CSK4, MALP2 or zymosan, seem to require CD14,
whereas ligands of TLR2-TLR1 heterodimers, such as
Pam3CSK4, bind and signal independently of CD14 [1, 28, 29].
It should be emphasized that the MyD88-deficient mice are dis-
tinctly more susceptible to L. monocytogenes infection than
TLR2-deficient or CD14-deficient mice (figure 2D). Previously,
a high sensitivity to Listeria infection was reported for MyD88-
deficient mice, but interestingly, an adaptive immune response
with protective immunitywas obtained in the absence ofMyD88
[30].MyD88 is further involved in crosstalkwith other pathways
such as the focal adhesion kinase [31] that may play a role in the
Figure 5. CD14-dependent recruitment and activation of macrophages
in the liver. CD14-deficient mice and control mice were infected with
3  104 colony-forming units of Listeria monocytogenes, and mononu-
clear cells from the liver were isolated 2 days after infection (4 mice per
group). The cells were stained with CD11b and CD40 and analyzed by
flow cytometry. Numbers are the percentage of double-positive cells in
the mononuclear cell population. Graphs show results from 1 experiment
that are representative of 2 independent experiments, expressed as mean
 SD (n  2).
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process of spreading Listeria infection. CD14 has so far not been
reported to be involved in receptor complexes other than TLR4
and TLR2, with the exception of TLR3. A TLR3 ligand poly-
inositine-cytosine analogue has been shown to activate antigen-
presenting cells in a TLR3- CD14 dependent manner, and a
ligand- TLR3-CD14 complex has been demonstrated [18].
CD14 seems to be involved in regulating neutrophil influx,
because CD14-deficient mice show increased expression of
CXCR2,MIP2, and neutrophil transmigration in pneumococcal
infection [32], whereas neutrophil migration was delayed in
CD14-deficientmice early after peritoneal infectionwith Salmo-
nella, acting through TLR4 [33]. Here, neutrophil recruitment
Figure 6. CD14-dependent nuclear factor B (NF-B) translocation and upregulation of CD40 and CD86 expression in Listeria monocytogenes
(LM)–infected bone marrow– derived macrophages (BMDMs). NF-B translocation in L. monocytogenes–infected macrophages (A). BMDMs from
C57BL/6 mice and CD14-deficient mice were stimulated for 1h with L. monocytogenes (MOI, 1:2), and NF-B staining was assessed. A quantitative
evaluation of the percentage of cells showing NF-B translocation is presented here as a bar graph. Reduced upregulation of CD40 and CD86 expression
(B) in CD14-deficient macrophages after L. monocytogenes or lipopolysaccharide (LPS) stimulation (2 mice per group). Graphs show results from 1
experiment representative of 3 independent experiments. Counts represent the relative cell number. MFI, mean fluorescence intensity.
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after L. monocytogenes infection is enhanced, resulting in large,
diffusemicroabscesses in the liver of CD14-deficientmice.How-
ever, the data suggest that macrophages and neutrophils from
CD14-deficientmice and TLR2-deficientmicemay be less effec-
tive in killing in vivo, as indicated by reduced iNOS expression in
the liver, although the macrophage mediated killing was not re-
duced in vitro. Reactive nitrogen is a key bactericidalmechanism
for mycobacteria [34] and Listeria [35]. However, the killing of
Listeria is further supported by reactive oxygen produced by
phagocytes oxidase (pg91phox). In fact, mice that are double-
deficient for pg91phox and NOS2 are more susceptible to Listeria
infection [35] than single-deficient mice, but the existence of
alternative mechanisms of killing is discussed [36].
Although we showed reduced resistance in TLR2-deficient
mice [5, 6] and CD14-deficient mice, the dramatically height-
ened susceptibility of MyD88-deficient mice that has bee de-
scribed before [5, 6] cannot be solely ascribed to defective TLR
sensing of L. monocytogenes. We have testedmost of the TLRs by
using single-gene deficient mice (data not shown), suggesting
that TLR2-CD14 may contribute to this heightened susceptibil-
ity, along with other non-TLR pathogen recognition receptors
on the membrane, which are yet to be identified.
Previous investigations demonstrated the induction of
MCP-1 in macrophages by L. monocytogenes and CCR2-
dependent recruitment and activation of monocytes [27]. The
induction of MCP-1 was found to be MyD88-dependent and
TLR2-independent. Edelson et al. [6] offer data that reinforce
the MyD88-dependent control of L. monocytogenes infection,
suggesting a contribution by IL-1 and IL-18 receptor pathways,
which depend on TLR signaling on the MyD88 adapter protein.
This hypothesis is further reinforced by reduced IL-1 production
in L. monocytogenes–infected, ASC-deficient macrophages [26].
Therefore, TLR2-CD14 and additional, undefined pattern rec-
ognition receptors induce IL-1 and IL-18, which are required,
together with IFN, IL-1, and TNF, to control L. monocytogenes
infection. However, a recent report demonstrated that IL-1 sig-
naling is dispensable for the control of systemic Listeria infec-
tion, but required to control cerebral listeriosis [37].
In conclusion, Listeria activates macrophages in vitro in a
CD14-dependent and/or TLR2-dependent manner. CD14 ex-
pression is required for host resistance to L. monocytogenes in-
fection in vivo; reducedCD14 expression results in bacterial per-
sistence, reduced NOS2 expression in the liver, and heightened
mortality. However, there is no additive effect with TLR2; mice
deficient in both CD14 and TLR2 have comparably heightened
susceptibility to Listeria infection.
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